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. Results for the whole lesion analysis in 9 animals scanned with Gadofosveset as well as Gd-DTPA. , Ali S. Arbab 1, 7 , and Hassan Bagher-Ebadian 1 . Methods: DCE T1 MRI studies were done in 9 Fisher 344 rats inoculated intracerebrally with 9L gliosarcoma cells. Animals were scanned using both gadofosveset and Gd-DTPA in the same animal 24 hours apart. T1-weighted multislice sequence (TR/TE=500/12 ms, 256 x 256 matrix, 13-15 slices, 1 mm thick, 40 x 30 mm field of view (FOV), number of excitations (NEX)=4). T2-weighted images were obtained using standard two-dimensional Fourier transformation (2DFT) multislice (13-15) multiecho (4 echoes) MRI. A series of 4 sets of images (13-15 slices for each set) were obtained using TEs of 15, 30, 45 and 60 msec and a TR of 1500 msec. The images were produced using 40 x 30 mm FOV, 1 mm slice thickness, 256 x 256 matrix, and NEX = 2-4. For DCE MRI, multi flip angle (2 to 35) fast SPGR 3D images were obtained to create T1 maps. Then dynamic images were obtained for 15 minutes using a fixed 30-degree flip angle. vp, K trans , and ve were estimated using nested model selection from the DCE data 1 , using a standardized arterial input function (AIF). Descriptive statistics were computed for the two contrast agents, as well as for the whole lesion and central core. Nonparametric Wilcoxon signed rank tests were done, and intra-class correlation coefficients (ICC) were computed to assess the agreement or reliability between the two contrast agents. Results: For the whole lesion, K trans measures were significantly lower (p=0.0039) using gadofosveset compared to Gd-DTPA, and there was almost perfect agreement between the two contrast agents. Both ve and vp, measurements were not statistically different, and there was almost perfect agreement for ve and substantial agreement for vp. For the central core, K trans was significantly lower (p=0.0039) using gadofosveset compared to Gd-DTPA, with substantial agreement. No difference was observed between the contrast agents for ve and vp. Substantial agreement was observed for vp, but not for ve which showed poor agreement. Discussion: Currently used low molecular weight extravascular contrast agents leak rapidly through the leaky tumor vasculature, where as albumin-bound intravascular contrast agents may provide a better assessment of the leakiness of vasculature due to their larger size and hence, more controlled leakage across the deficient BBB. DCE-MRI non-invasively measures tumor vascular kinetics; however, a robust postprocessing pharmacokinetic model is needed to obtain stable and accurate estimates of various vascular parameters (vp, K trans and ve), whether using extravascular or intravascular contrast agents 2, 3 . In this study, we have demonstrated that using DCE-MRI and NMS, K trans measures were significantly higher with Gd-DTPA due to its smaller size and rapid extravasation from the intravascular compartment compared to gadofosveset. This is consistent with previous literature showing that K trans values decreased with increasing molecular weight of the contrast agent 4 . K trans measures were also highly correlated using both contrast agents suggesting stability of the NMS DCE technique. Conclusion: In conclusion, both volume of extravascular extracellular space and blood plasma volume can be measured accurately whether we use an extravascular or intravascular contrast agent in an animal glioma model. K trans measurements were significantly lower using a blood pool contrast agent due to the much larger size of the albumin-bound contrast agent, and these were measured with very good accuracy using NMS in DCE-MRI. The goal of this research is to demonstrate the stability of NMS in DCE-MRI for measurement of these important vascular physiology markers which can provide important information about the tumor microenvironment, and hence, could potentially expand their role into prognostic or predictive imaging biomarkers, an area of very active clinical interest. 
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